1,2-Didehydrotanshinone IIACAS# 119963-50-7 |
2D Structure
Quality Control & MSDS
3D structure
Package In Stock
Number of papers citing our products
Cas No. | 119963-50-7 | SDF | Download SDF |
PubChem ID | 128994 | Appearance | Red powder |
Formula | C19H16O3 | M.Wt | 292.3 |
Type of Compound | Diterpenoids | Storage | Desiccate at -20°C |
Solubility | Soluble in Chloroform,Dichloromethane,Ethyl Acetate,DMSO,Acetone,etc. | ||
Chemical Name | 1,6,6-trimethyl-7H-naphtho[1,2-g][1]benzofuran-10,11-dione | ||
SMILES | CC1=COC2=C1C(=O)C(=O)C3=C2C=CC4=C3C=CCC4(C)C | ||
Standard InChIKey | PURTYNPVRFEUEN-UHFFFAOYSA-N | ||
General tips | For obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20℃ for several months. We recommend that you prepare and use the solution on the same day. However, if the test schedule requires, the stock solutions can be prepared in advance, and the stock solution must be sealed and stored below -20℃. In general, the stock solution can be kept for several months. Before use, we recommend that you leave the vial at room temperature for at least an hour before opening it. |
||
About Packaging | 1. The packaging of the product may be reversed during transportation, cause the high purity compounds to adhere to the neck or cap of the vial.Take the vail out of its packaging and shake gently until the compounds fall to the bottom of the vial. 2. For liquid products, please centrifuge at 500xg to gather the liquid to the bottom of the vial. 3. Try to avoid loss or contamination during the experiment. |
||
Shipping Condition | Packaging according to customer requirements(5mg, 10mg, 20mg and more). Ship via FedEx, DHL, UPS, EMS or other couriers with RT, or blue ice upon request. |
Description | 1. 1,2-Didehydrotanshinone IIA shows inhibitory effects against acetyl- (AChE) and butyrylcholinesterase (BChE). 2. 1,2-Didehydrotanshinone IIA possesses metal-chelation capacity. |
Targets | AChR |
1,2-Didehydrotanshinone IIA Dilution Calculator
1,2-Didehydrotanshinone IIA Molarity Calculator
1 mg | 5 mg | 10 mg | 20 mg | 25 mg | |
1 mM | 3.4211 mL | 17.1057 mL | 34.2114 mL | 68.4229 mL | 85.5286 mL |
5 mM | 0.6842 mL | 3.4211 mL | 6.8423 mL | 13.6846 mL | 17.1057 mL |
10 mM | 0.3421 mL | 1.7106 mL | 3.4211 mL | 6.8423 mL | 8.5529 mL |
50 mM | 0.0684 mL | 0.3421 mL | 0.6842 mL | 1.3685 mL | 1.7106 mL |
100 mM | 0.0342 mL | 0.1711 mL | 0.3421 mL | 0.6842 mL | 0.8553 mL |
* Note: If you are in the process of experiment, it's necessary to make the dilution ratios of the samples. The dilution data above is only for reference. Normally, it's can get a better solubility within lower of Concentrations. |
Calcutta University
University of Minnesota
University of Maryland School of Medicine
University of Illinois at Chicago
The Ohio State University
University of Zurich
Harvard University
Colorado State University
Auburn University
Yale University
Worcester Polytechnic Institute
Washington State University
Stanford University
University of Leipzig
Universidade da Beira Interior
The Institute of Cancer Research
Heidelberg University
University of Amsterdam
University of Auckland
TsingHua University
The University of Michigan
Miami University
DRURY University
Jilin University
Fudan University
Wuhan University
Sun Yat-sen University
Universite de Paris
Deemed University
Auckland University
The University of Tokyo
Korea University
- Peroxy Orange 1
Catalog No.:BCC6336
CAS No.:1199576-10-7
- 7-O-Methylmorroniside
Catalog No.:BCN7293
CAS No.:119943-46-3
- CGRP 8-37 (human)
Catalog No.:BCC5724
CAS No.:119911-68-1
- Posaconazole hydrate
Catalog No.:BCC4234
CAS No.:1198769-38-8
- Esomeprazole magnesium salt
Catalog No.:BCC5430
CAS No.:1198768-91-0
- Phyperunolide E
Catalog No.:BCN7292
CAS No.:1198400-52-0
- Coptisine sulfate
Catalog No.:BCN2286
CAS No.:1198398-71-8
- Cerdulatinib (PRT062070)
Catalog No.:BCC8068
CAS No.:1198300-79-6
- Sodium Channel inhibitor 1
Catalog No.:BCC1959
CAS No.:1198117-23-5
- Mirin
Catalog No.:BCC5986
CAS No.:1198097-97-0
- AP26113
Catalog No.:BCC1069
CAS No.:1197958-12-5
- 3-Furfuryl 2-pyrrolecarboxylate
Catalog No.:BCN6086
CAS No.:119767-00-9
- INT-777
Catalog No.:BCC5390
CAS No.:1199796-29-6
- Unedone
Catalog No.:BCN6759
CAS No.:1199815-09-2
- Sulfuretin
Catalog No.:BCN4725
CAS No.:120-05-8
- Scoparone
Catalog No.:BCN6088
CAS No.:120-08-1
- Veratraldehyde
Catalog No.:BCN6089
CAS No.:120-14-9
- Tropine benzilate
Catalog No.:BCN1921
CAS No.:3736-36-5
- Clorofene
Catalog No.:BCC8919
CAS No.:120-32-1
- 3-Amino-4-methoxybenzanilide
Catalog No.:BCC8613
CAS No.:120-35-4
- Desoxyanisoin
Catalog No.:BCN2264
CAS No.:120-44-5
- Ethylparaben
Catalog No.:BCN6094
CAS No.:120-47-8
- Benzyl benzoate
Catalog No.:BCN8521
CAS No.:120-51-4
- Isosafrole
Catalog No.:BCC3976
CAS No.:120-58-1
Selective in vitro and in silico butyrylcholinesterase inhibitory activity of diterpenes and rosmarinic acid isolated from Perovskia atriplicifolia Benth. and Salvia glutinosa L.[Pubmed:27817931]
Phytochemistry. 2017 Jan;133:33-44.
Cholinesterase inhibition is one of the most treatment strategies against Alzheimer's disease (AD) where metal accumulation is also strongly associated with pathology of the disease. In the current study, we assessed inhibitory effect against acetyl- (AChE) and butyrylcholinesterase (BChE) and metal-chelating capacity of twelve diterpenes: arucadiol, miltirone, tanshinone IIa, 1-oxomiltirone, cryptotanshinone, 1,2-didehydromiltirone, 1,2-Didehydrotanshinone IIA, 1beta-hydroxycryptotanshinone, 15,16-dihydrotanshinone, tanshinone I, isotanshinone II, 1(S)-hydroxytanshinone IIa, and rosmarinic acid, isolated from Perovskia atriplicifolia and Salvia glutinosa. The compounds were tested at 10 mug/mL using ELISA microtiter assays against AChE and BChE. QSAR and molecular docking studies have been also performed on the active compounds. All of the compounds showed higher [e.g., IC50 = 1.12 +/- 0.07 mug/mL for 1,2-didehydromiltirone, IC50 = 1.15 +/- 0.07 mug/mL for cryptotanshinone, IC50 = 1.20 +/- 0.03 mug/mL for arucadiol, etc.)] or closer [1,2-Didehydrotanshinone IIA (IC50 = 5.98 +/- 0.49 mug/mL) and 1(S)-hydroxytanshinone IIa (IC50 = 5.71 +/- 0.27 mug/mL)] inhibition against BChE as compared to that of galanthamine (IC50 = 12.56 +/- 0.37 mug/mL), whereas only 15,16-dihydrotanshinone moderately inhibited AChE (65.17 +/- 1.39%). 1,2-Didehydrotanshinone IIA (48.94 +/- 0.26%) and 1(S)-hydroxytanshinone IIa (47.18 +/- 5.10%) possessed the highest metal-chelation capacity. The present study affords an evidence for the fact that selective BChE inhibitors should be further investigated as promising candidate molecules for AD therapy.
Isolation and Fast Selective Determination of Nor-abietanoid Diterpenoids from Perovskia atriplicifolia Roots Using LC-ESI-MS/MS with Multiple Reaction Monitoring.[Pubmed:26410997]
Nat Prod Commun. 2015 Jul;10(7):1149-52.
In the first part of this study we extracted, isolated, and identified the main diterpenoid constituents from the roots of a Central Asian medicinal and ornamental plant--Perovskia atriplicifolia Benth. Eight major nor-abietanoid pigments were obtained using NP silica gel column chromatography and preparative RP-HPLC: cryptotanshinone, 1-hydroxycryptotanhinone, miltirone, 1-oxomiltirone, tanshinone IIa, 1,2 didehydrotanshinone IIa, 1,2 didehydromiltirone, the non-quinone diterpenoid - arucadiol, as well as rosmarinic acid as a main phenolic compound. Secondly, we used the obtained compounds for fast and selective determination of the main diterpenes present in P. atriplicifolia root extract. After extraction with n-hexane, the quantitative analysis was carried out by LC-MS/MS with a triple quadrupole (qQq) mass detector without any prior clean-up step. Identification of the diterpenes was confirmed by multiple reaction monitoring (MRM) using the most representative transitions from the precursor ions, while the most sensitive transitions were used for quantification in a 19-minute run. Most of the isolated and analyzed compounds had not been previously reported from this species. This easily cultivated plant is a promising source of several pharmacologically valuable abietanoid diterpenoids.